Cytek Biosciences, Inc. Common Stock (CTKB) Stock Price

CTKBStock

$4.58+6.99%52W

Market Cap$595.32M

P/E—

PEG Ratio—

Div yield—

Beta1.19

CTKB Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-5.53%

Price vs S&P 500 (4W)-3.50%

VGM Score50.87

P/CF (Annual)22.57x

Book Value / Share (Quarterly)$2.48

P/TBV (Annual)1.99x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)7.10%

Cash Flow / Share (Quarterly)$-0.09

Price vs S&P 500 (YTD)-24.04%

Gross Margin (TTM)53.23%

Net Profit Margin (TTM)-38.98%

EPS (TTM)$-0.63

10-Day Avg Trading Volume0.88M

EPS Excl Extra (TTM)$-0.63

Revenue Growth (5Y)16.77%

EPS (Annual)$-0.52

ROI (Annual)-19.09%

Gross Margin (Annual)51.84%

Net Profit Margin (5Y Avg)-7.68%

Cash / Share (Quarterly)$2.02

Revenue Growth QoQ (YoY)5.57%

ROA (Last FY)-14.42%

Revenue Growth TTM (YoY)5.44%

EBITD / Share (TTM)$-0.29

ROE (5Y Avg)-4.55%

Operating Margin (TTM)-21.60%

Cash Flow / Share (Annual)$-0.07

P/B Ratio1.97x

P/B Ratio (Quarterly)1.78x

Net Income / Employee (Annual)$-94,800

EV / Revenue (TTM)2.76x

Net Interest Coverage (TTM)4.47x

ROA (TTM)-17.40%

EV / EBITDA (TTM)840.36x

EPS Incl Extra (Annual)$-0.52

Current Ratio (Annual)5.04x

Quick Ratio (Quarterly)3.77x

3-Month Avg Trading Volume1.20M

52-Week Price Return6.99%

EV / Free Cash Flow (Annual)22.53x

Revenue / Employee (TTM)$294,500

Tangible BV / Share (Quarterly)$2.36

P/S Ratio (Annual)3.15x

Asset Turnover (Annual)0.44x

52-Week High$6.18

Operating Margin (5Y Avg)-7.72%

EPS Excl Extra (Annual)$-0.52

CapEx CAGR (5Y)22.00%

26-Week Price Return5.71%

Quick Ratio (Annual)4.27x

13-Week Price Return12.12%

Total Debt / Equity (Annual)0.02x

Current Ratio (Quarterly)4.48x

Enterprise Value$571.45M

Revenue / Share Growth (5Y)17.33%

Asset Turnover (TTM)0.45x

Revenue / Employee (Annual)$287,000

Inventory Turnover (Annual)2.10x

Pretax Margin (Annual)-14.81%

Cash / Share (Annual)$2.03

3-Month Return Std Dev48.63%

Gross Margin (5Y Avg)57.47%

Net Income / Employee (TTM)$-114,800

ROE (Last FY)-19.47%

Net Interest Coverage (Annual)-0.26x

EPS Basic Excl Extra (Annual)$-0.52

P/FCF (TTM)29.36x

Receivables Turnover (TTM)3.90x

Total Debt / Equity (Quarterly)0.03x

EPS Incl Extra (TTM)$-0.63

Receivables Turnover (Annual)3.27x

ROI (TTM)-22.93%

P/S Ratio (TTM)3.07x

Pretax Margin (5Y Avg)-4.08%

Revenue / Share (Annual)$1.58

Tangible BV / Share (Annual)$2.53

Price vs S&P 500 (52W)-11.32%

Year-to-Date Return-12.08%

5-Day Price Return-4.93%

EPS Normalized (Annual)$-0.52

ROA (5Y Avg)-3.39%

Net Profit Margin (Annual)-33.02%

Month-to-Date Return5.21%

Cash Flow / Share (TTM)$-0.06

EBITD / Share (Annual)$-0.26

Operating Margin (Annual)-20.04%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-4.46%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.63

P/TBV (Quarterly)1.86x

P/B Ratio (Annual)1.89x

Inventory Turnover (TTM)1.90x

Pretax Margin (TTM)-19.75%

Book Value / Share (Annual)$2.66

Price vs S&P 500 (13W)9.33%

Beta1.19x

P/FCF (Annual)29.36x

Revenue / Share (TTM)$1.60

ROE (TTM)-23.53%

52-Week Low$3.28

vGradeC

gGradeC

mGradeC

vgmGradeC

CTKB Earnings Surprise History

Q2 25-0.01est. -0.01

Q3 25-0.00est. 0.01

Q4 25-0.29est. 0.01

Q1 26-0.10est. -0.08

Q2 26-0.03est. -0.02

CTKB Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.00

Industry Peers — Lab Analytical Instruments(26)

Symbol	Value Score	Growth Score	Momentum Score	Price
CTKBCytek Biosciences, Inc. Common Stock	C	C	C	$4.58
AAgilent Technologies Inc.	D	C	B	$154.77
WATWaters Corp	D	C	B	$414.44
ILMNIllumina Inc	D	D	A	$224.99
MTDMettler-Toledo International	D	C	B	$1402.25
RVTYRevvity, Inc.	C	D	B	$124.84
BIOBio-Rad Laboratories, Inc.Class A	C	D	B	$390.34
BIO.BBio-Rad Laboratories, Inc. Class B	C	D	B	$365.08
AVTRAvantor, Inc.	B	F	A	$14.42
BRKRBruker Corporation	D	D	B	$56.85
TXG10x Genomics, Inc. Class A Common Stock	F	D	A	$64.72
ALMRAlamar Biosciences, Inc. Common Stock	—	—	A	$33.02
PACBPacific Biosciences of California, Inc.	D	C	C	$1.52
MASS908 Devices Inc. Common Stock	C	C	A	$11.00
EYPTEyePoint, Inc. Common Stock	D	F	F	$5.00
PREPrenetics Global Limited Class A Ordinary Share	C	D	A	$23.25
LABStandard BioTools Inc. Common Stock	A	F	D	$0.65
QTRXQuanterix Corporation Common Stock	A	C	C	$2.79
SEERSeer, Inc. Class A Common Stock	C	D	C	$2.04
NAUTNautilus Biotechnolgy, Inc. Common Stock	—	—	C	$0.88
RPIDRapid Micro Biosystems, Inc. Class A Common Stock	C	B	D	$1.66
PRPOPrecipio, Inc. Common Stock	C	A	A	$30.85
HBIOHarvard Bioscience Inc	B	F	A	$7.58
ASTCAstrotech Corporation (DE) Common Stock	C	C	A	$7.10
BNGOBionano Genomics, Inc. Common Stock	A	C	C	$1.25
HLTHTema Healthcare AI ETF	—	F	D	$29.92
PRENWPrenetics Global Limited Warrant	—	—	D	$0.01

About Cytek Biosciences, Inc. Common Stock

Cytek Biosciences develops full-spectrum flow cytometry systems that enable high-resolution, sensitive cell analysis at a lower cost than conventional technologies. Its Aurora and Northern Lights platforms leverage advanced fluorescence detection to deliver superior analytical power and flexibility for research and diagnostics applications. The company generates the majority of its revenue from the United States.